On Wednesday, the world’s top biotechnology companies agreed to a $20 billion agreement to develop and commercialize three new bioinactive materials.

The companies—Biofuel, Bio-Labs, and Synthetic Genomics Technologies—are each looking to develop three new products, all of which will be manufactured using existing materials, the companies announced Wednesday.

The Biofuel product is a novel compound called Sulfur Dioxide (SDE) that is an alternative to gasoline.

The SDE is made of two types of sulfate, one of which can be used to convert sunlight into hydrogen, and another of which is a chemical known as the hydrogen ion.

The compound can be made from Sulfate, which is more stable and less toxic than carbon dioxide.

The new Bio-Lab products are carbon dioxide reductase inhibitors, which are intended to reduce carbon dioxide in the atmosphere, and nitric oxide, which can act as a catalyst for carbon dioxide reduction.

The Synthetic Genetics Technology (SGT) product is designed to create genetically engineered plants that will produce a biofuel based on natural sources of carbon dioxide, which they hope will be sold in large quantities.

The Bioprocessing Technology (BTP) product will use enzymes to convert sugars into energy.

The enzymes are derived from plant material.

The Sulfurococcus Biosig (SBC) product uses enzymes that convert the amino acids that are essential for life to be produced in the lab.

It is intended to be sold to biofuels companies to make the ingredients used to make biofuel.

The final Bio-Fuel product is called Sustainable Bioinorganic Chemistry (SBS), which is intended for use in a wide variety of biofuilment applications, including biofueling.

The biosig technology companies said they were confident they could create the next generation of products, and they plan to bring these technologies to market within the next decade.

The three companies also agreed to collaborate to further develop a wide range of new products and to launch an international consortium of bioinformaticians, chemists, and other researchers to further advance bioinformatics research.